Cargando…
OR12-04 LEAP2 Deletion Does Not Counteract The Effects Of Ghrelin Deletion During Insulin-Induced-Hypoglycemia
Disclosure: K. Shankar: None. S. Varshney: None. D. Gupta: None. O. Singh: None. S.B. Ogden: None. S. Osborne-Lawrence: None. N.P. Metzger: None. C.P. Richard: None. J.M. Zigman: Grant Recipient; Self; Novo Nordisk. Objective: The hormones ghrelin and LEAP2 both are endogenous ligands for the growth...
Autores principales: | Shankar, Kripa, Varshney, Salil, Gupta, Deepali, Singh, Omprakash, Ogden, Sean B, Osborne-Lawrence, Sherri, Metzger, Nathan P, Richard, Corine P, Marc Zigman, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555653/ http://dx.doi.org/10.1210/jendso/bvad114.890 |
Ejemplares similares
-
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
por: Shankar, Kripa, et al.
Publicado: (2021) -
THU309 Ghrelin Deficiency Does Not Improve Glucose Tolerance And Insulin Secretion In Female Mice
por: Gupta, Deepali, et al.
Publicado: (2023) -
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
por: Shankar, Kripa, et al.
Publicado: (2023) -
“A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”
por: Gupta, Deepali, et al.
Publicado: (2020) -
Role of Growth Hormone in Ghrelin’s Metabolic Actions
por: Gupta, Deepali, et al.
Publicado: (2021)